THE ONCOLOGY INSTITUTE

DFP Healthcare Acquisitions Corp. Announces Special Meeting Date to Approve Proposed Business Combination with The Oncology Institute

Retrieved on: 
Friday, October 22, 2021
Finance, Hospitals, Health, Professional Services, Oncology, American Oncology Institute, Registration statement, Securities Act of 1933, Park Avenue, Name, Failure, Eastern Time Zone, Proxy statement, Person, Date, Security (finance), U.S. Securities and Exchange Commission, Patient, Private Securities Litigation Reform Act, DFP, SEC, Probability, TOI, Oncology, Communication, Risk, Forward-looking statement, Company, COVID-19, Health, Prospectus, Special, Acquisition, Population, Therapy, Business architecture, Proxy, Register, Sale, Form, Property management, The Oncology Institute, DFP Healthcare Acquisitions Corp., THE ONCOLOGY INSTITUTE, DFP HEALTHCARE ACQUISITIONS CORP.

DFP Healthcare Acquisitions Corp. (DFP) (Nasdaq: DFPH) announced today that it has scheduled the special meeting of its stockholders (the Special Meeting) for November 12, 2021 at 10:00 a.m., Eastern Time, to approve the proposed business combination (the Business Combination) with The Oncology Institute (TOI or the Company), the U.S. market leader in providing value-based oncology care.

Key Points: 
  • DFP Healthcare Acquisitions Corp. (DFP) (Nasdaq: DFPH) announced today that it has scheduled the special meeting of its stockholders (the Special Meeting) for November 12, 2021 at 10:00 a.m., Eastern Time, to approve the proposed business combination (the Business Combination) with The Oncology Institute (TOI or the Company), the U.S. market leader in providing value-based oncology care.
  • About DFP Healthcare Acquisitions Corp.
    DFP Healthcare Acquisitions Corp. is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
  • The Companys strategy will be to identify, acquire and, after its initial business combination, build, a healthcare or healthcare related business.
  • DFP and its directors and executive officers may be deemed participants in the solicitation of proxies from DFPs stockholders with respect to the proposed Business Combination.